Your Complete Guide to Global Clinical Research and GCP Compliance
How to Design Statistical Analysis Plan (SAP) & DMC Charter That Aligns With GCP, ICH and Regulatory Guidance How to Design Statistical Analysis Plan (SAP) & DMC Charter That Aligns With GCP, ICH and Regulatory Guidance The successful execution of clinical trials hinges significantly on the meticulous design of the Statistical Analysis Plan (SAP) and…
Distinguishing Systemic vs Isolated Non-Compliance in Clinical Trials In the realm of clinical trials, compliance to protocols is crucial for ensuring the integrity of data, patient safety, and the overall success of research. This article provides a detailed guide on identifying and managing systemic versus isolated non-compliance within clinical trial settings, specifically tailored for clinical…
Read More “Distinguishing Systemic vs Isolated Non-Compliance in Clinical Trials” »
Risk Indicators That a Deviation Pattern Reflects Systemic Weakness Identifying Risk Indicators of Systemic Weakness in Clinical Deviations In the realm of clinical research, understanding the distinction between systemic and isolated non-compliance with regulatory standards is crucial. It is essential for ensuring the integrity of data generated during clinical trials. Clinical operations, regulatory affairs, and…
Read More “Risk Indicators That a Deviation Pattern Reflects Systemic Weakness” »
Device & Diagnostic Transparency: Compliance Strategy for US, EU and UK Clinical Programs Device & Diagnostic Transparency: Compliance Strategy for US, EU and UK Clinical Programs In an increasingly regulated environment for clinical trials, ensuring transparency in device and diagnostic development has become a paramount responsibility for clinical operations, regulatory affairs, and medical affairs professionals….
How to Design Device & Diagnostic Transparency That Meets FDA, EMA and MHRA Expectations How to Design Device & Diagnostic Transparency That Meets FDA, EMA and MHRA Expectations Introduction to Clinical Trial Transparency Transparency in clinical trials is crucial for regulatory compliance and ethical research practices. In the context of medical devices and diagnostics, regulatory…
Statistical Analysis Plan (SAP) & DMC Charter: Inspection-Ready Standards for US, UK and EU Clinical Trials Introduction to Statistical Analysis Plan (SAP) and DMC Charter The development of a Statistical Analysis Plan (SAP) and a Data Monitoring Committee (DMC) Charter is a critical component in the successful conduct of clinical trials. These documents serve as…
Sponsor–CRO Collaboration on Feasibility to Minimize Non-Compliance Sponsor–CRO Collaboration on Feasibility to Minimize Non-Compliance In the realm of registrational clinical trials, ensuring compliance with the protocol is critical to both participant safety and the integrity of the collected data. Non-compliance can not only result in wasted resources but can also jeopardize the overall success of…
Read More “Sponsor–CRO Collaboration on Feasibility to Minimize Non-Compliance” »
Regulatory Expectations for Realistic, Implementable Protocols In the dynamic landscape of clinical research, organizations must navigate a complex array of regulations and best practices to ensure compliance while conducting effective clinical trials. This tutorial offers a structured approach to understanding the regulatory expectations for realistic and implementable protocols, focusing on key lessons learned from protocol…
Read More “Regulatory Expectations for Realistic, Implementable Protocols” »
Using Journal Policies & Preprints to Support Publications, HTA and Market Access Using Journal Policies & Preprints to Support Publications, HTA and Market Access The integration of real-world evidence (RWE) into clinical development and the dissemination of research findings play a pivotal role in the regulatory landscape, particularly concerning Health Technology Assessment (HTA) and market…
Read More “Using Journal Policies & Preprints to Support Publications, HTA and Market Access” »
Future Trends: AI, Real-World Data and Evolving Rules for Journal Policies & Preprints Future Trends: AI, Real-World Data and Evolving Rules for Journal Policies & Preprints In the evolving landscape of clinical research, understanding the intersection of artificial intelligence (AI), real-world data (RWD), and journal publication policies is paramount for clinical operations, regulatory affairs, and…
Read More “Future Trends: AI, Real-World Data and Evolving Rules for Journal Policies & Preprints” »
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.